Novartis Reports Q3 Earnings Beat and Upgrades Full-Year Core Operating Income Outlook
Novartis reported third-quarter non-GAAP earnings per share of $2.46, exceeding analyst expectations by $0.22. While total revenue reached $14.52 billion—a 4.4% year-over-year increase—it slightly missed consensus estimates by approximately $40 million. The company demonstrated strong operational efficiency with core operating income rising 10% in constant currency. Following these results, Novartis upgraded its full-year outlook for core operating income, signaling confidence in its ongoing growth trajectory and margin management.
Tickers: $NVS
Topics: earnings beat net sales growth operating income revenue miss
Read the full article at Seeking Alpha
Part of the story Zedge Reports Q4 Revenue Beat and Significant Free Cash Flow Growth (3 articles)